Literature DB >> 11068306

Family history and the risk of prostate cancer.

L A Kalish1, W S McDougal, J B McKinlay.   

Abstract

OBJECTIVES: Several studies have identified prostate cancer family history as a risk factor for prostate cancer incidence, typically associated with a twofold to fourfold increase in risk. A family history of breast cancer has also been implicated. We investigated the associations between prostate cancer incidence and family histories of prostate and breast cancer, controlling for possible confounding due to environmental factors.
METHODS: Data from the random sample-based Massachusetts Male Aging Study cohort (1987 to 1997) were used. Incidence rates were calculated as the number of cases per person-year of follow-up. Covariates were adjusted for using Poisson regression.
RESULTS: Among 1149 men with an average of 8.7 person-years of follow-up, 57 were diagnosed with prostate cancer, 110 men reported a prostate cancer family history, and 157 reported a breast cancer family history. The age-adjusted relative risk (RR) of prostate cancer incidence associated with prostate cancer family history was 3.29 (95% confidence interval [CI] 1.82 to 5.94). No evidence of heterogeneity was found across age levels (P = 0.83). Additional adjusting for environmental factors such as smoking, alcohol use, body mass index, physical activity, education, sexually transmitted disease history, diet, and hormone levels yielded a slightly higher RR (3.78, 95% CI 1.96 to 7.28). No association with a family history of breast cancer was evident (RR = 1.18, 95% CI 0.51 to 2.43).
CONCLUSIONS: We found an association between prostate cancer incidence and a family history of prostate cancer, independent of environmental factors. No association with a family history of breast cancer was evident.

Entities:  

Mesh:

Year:  2000        PMID: 11068306     DOI: 10.1016/s0090-4295(00)00780-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.

Authors:  Evelyn C Y Chan; Michael J Barry; Sally W Vernon; Chul Ahn
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

2.  Family History of Breast or Prostate Cancer and Prostate Cancer Risk.

Authors:  Lauren Barber; Travis Gerke; Sarah C Markt; Samuel F Peisch; Kathryn M Wilson; Thomas Ahearn; Edward Giovannucci; Giovanni Parmigiani; Lorelei A Mucci
Journal:  Clin Cancer Res       Date:  2018-08-06       Impact factor: 12.531

3.  Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.

Authors:  Yen-Ching Chen; Edward Giovannucci; Peter Kraft; David J Hunter
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

4.  Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.

Authors:  Bao-Li Chang; Lucinda Hughes; David Y T Chen; Laura Gross; Karen Ruth; Veda N Giri
Journal:  BJU Int       Date:  2013-08-13       Impact factor: 5.588

5.  An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.

Authors:  Michał Kiciński; Jaco Vangronsveld; Tim S Nawrot
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

6.  Comparison of the Effect of Intra-Rectal Administration of Lidocaine Gel and Lidocaine Plus Fentanyl on Pain Reduction in Prostate Biopsy: A Randomized Clinical Trial.

Authors:  Farsad Imani; Mohammadreza Khajavi; Tayeb Gavili; Pejman Pourfakhr; Reza Shariat Moharari; Farhad Etezadi; Seyed Reza Hosseini
Journal:  Anesth Pain Med       Date:  2018-11-28

7.  Ambient air pollution and prostate cancer risk in a population-based Canadian case-control study.

Authors:  Leslie Michele-Ange Kouam Youogo; Marie-Elise Parent; Perry Hystad; Paul J Villeneuve
Journal:  Environ Epidemiol       Date:  2022-07-19

8.  Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.

Authors:  Niklas Loman; Anna Bladström; Oskar Johannsson; Ake Borg; Håkan Olsson
Journal:  Breast Cancer Res       Date:  2003-08-07       Impact factor: 6.466

Review 9.  Recent Insights on Genetic Testing in Primary Prostate Cancer.

Authors:  Mona Kafka; Cristian Surcel; Isabel Heidegger
Journal:  Mol Diagn Ther       Date:  2021-06-12       Impact factor: 4.074

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.